Filing Details
- Accession Number:
- 0001209191-19-061657
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-20 19:44:53
- Reporting Period:
- 2019-12-19
- Accepted Time:
- 2019-12-20 19:44:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 876378 | Transenterix Inc. | TRXC | Surgical & Medical Instruments & Apparatus (3841) | 112962080 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1324130 | Jr N William Starling | 345 Golden Hills Drive Portola Valley CA 94028 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-12-19 | 3,587 | $1.39 | 17,983 | No | 4 | S | Indirect | See Footnote |
| Common Stock | Disposition | 2019-12-19 | 6,015 | $1.44 | 11,968 | No | 4 | S | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Footnote |
| No | 4 | S | Indirect | See Footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 18,134 | Indirect | See Footnote |
| Common Stock | 131,102 | Indirect | See Footnote |
| Common Stock | 1,568 | Direct |
Footnotes
- Shares of Common Stock sold by W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990.
- Reflects a reverse stock split of the Registrant's common stock at a ratio of one-for-thirteen with marketplace effectiveness on December 12, 2019 whereby the resulting fractional share was rounded up to the nearest whole share.
- The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.44 to $1.445 inclusive. The reporting person undertakes to provide to the Registrant, any security holder of the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- Shares of Common Stock held by Synecor, L.L.C. Willam N. Starling is the chief executive officer of Synecor, L.L.C.
- Shares of Common Stock held by Synergy Life Science Partners, L.P. William N. Starling is a managing director of Synergy Life Science Partners, L.P.
Billionaire Hedge Funds
